Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study status changed from Active, not recruiting to Completed, with the study completion date updated to 2026-02-20 and related dates adjusted accordingly.SummaryDifference0.1%

- Check10 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision indicator updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded UI elements and data fields: Show glossary, Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed prior UI/data fields: Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check46 days agoChange DetectedResults for NCT04221945 were posted on 2026-01-05, including updated PFS and OS definitions and their assessment methods (investigator and BICR). It also notes IPD sharing availability and provides related data-access documents.SummaryDifference1%

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.